Requested by: Stuff NZ | Response provided: 01/06/2021
Category: Clinical
  1. Any reports, emails, correspondence, briefing documents and advice produced by and for Counties Manukau DHB between September 9 and December 21, 2020 relating to the decision to change the Special Authority criteria for Empagliflozin and Dulaglutide.
  2. Also include any correspondence, emails and advice between Counties Manukau DHB and Pharmac and the Minister of Health during the same timeframe regarding the two drugs.


Last modified: